CAG
JAZZ icon

Crestwood Advisors Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Crestwood Advisors Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$376K Buy
1,561
+477
+44% +$105K 0.01% 591
2026
Q1 		$205K Buy
+1,084
New +$189K ﹤0.01% 730

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Crestwood Advisors Group's JAZZ Position: Q2 2026 in Review

Crestwood Advisors Group increased its Jazz Pharmaceuticals (JAZZ) stake by 44% in Q2 2026, buying an estimated $105K and bringing the position to 1,561 shares worth $376K. The position accounts for 0.01% of the portfolio, ranked #591.

Crestwood Advisors Group first reported a position in JAZZ in Q1 2026 and has held it in 2 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Crestwood Advisors Group held 1,561 shares of Jazz Pharmaceuticals worth $376K as of Q2 2026.
  • Crestwood Advisors Group bought 477 Jazz Pharmaceuticals shares in Q2 2026, an estimated $105K.
  • Jazz Pharmaceuticals made up 0.01% of Crestwood Advisors Group's portfolio in Q2 2026, its #591 holding.
  • Crestwood Advisors Group first reported a position in Jazz Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Crestwood Advisors Group's 13F filing for Q2 2026, filed 3 Aug 2026.